My Wellbeing Guide for Cancer-Related Stress and Depressive Symptoms
This study is testing an online program called "My Wellbeing Guide" to help cancer patients manage stress and improve their quality of life. This program uses cognitive behavioral therapy (a type of talk therapy) through animated videos, activities, and written content over 7 weeks. We want to see if it helps reduce depressive symptoms in people with cancer who are receiving care at Northwestern Medicine or the University of Miami Health System. You might be eligible if you are 18 or older, have a cancer diagnosis, have elevated depressive symptoms, and have internet access. The study team will contact eligible patients directly.
- Study design
- This is an interventional study planning to enroll 6516 participants. It is not specified if it is randomized or blinded.
- What's involved
- Participants will use the online "My Wellbeing Guide" program for 7 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your depressive symptoms will be checked at 7 weeks, 6 months, and 12 months after starting the program.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life
At a glance
Conditions
NCT05369429
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Northwestern University
Chicago, Illinoisstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Betina Yanez, PhD · PRINCIPAL_INVESTIGATOR · Northwestern University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in depressive symptoms will be evaluated with the Patient-Reported Outcomes Measurement Information System DepressionT1 (prior to starting intervention), T2 (7 weeks post intervention), T3 (6 months post-intervention), T4 (12 months post-intervention)
The Patient-Reported Outcomes Measurement Information System (PROMIS) Depression questionnaire is a previously validated patient-report measure of depressive symptoms in the last seven days. Scores generally range from 20 - 80, with higher scores indicating a patient is reporting more severe levels of depression.